781.238.8402 batl@northeastern.edu

The Biopharmaceutical Analysis Training Laboratory (BATL)

Committed to Global
Regulatory Convergence

VISION

BATL serves as a global facilitator and a neutral platform in leading the way in regulatory convergence training to get drugs to patients quickly and safely. It is at the forefront of medical regulatory convergence, ensuring patient safety and access—no matter the cost.

 

MISSION

A resource for training – online, in workshops, and through experiential learning – on the intricacies of regulatory considerations for pharmaceutical and biopharmaceutical products.  A global facilitator of collaboration between academia, industry and government towards regulatory convergence.

CRASH COURSE:

Ask about our one-day crash course in Protein Structure Analytics in Developing Biopharmaceuticals.

FEATURED PROGRAM:

Learn about our upcoming Pharmaceutical Quality Training Program

CONNECT:

If you have any questions about what we do, our courses, or our global impact, feel free to reach out. 

NEWS:

BATL is helping communities around the world. Learn about where and how we are making a difference. 

A COMMITMENT TO
EXPERIENTIAL TRAINING

Research in biotherapeutics is providing promising and innovative drugs that provide hope to millions of patients around the world. Yet these same drugs may pose risks, especially if the challenges inherent in their production, distribution, and marketing are not properly understood and regulated.

The Center of Excellence for Biotherapeutics at Northeastern University’s Biopharmaceutical Analysis Training Laboratory (BATL) will help build expertise and know-how by bringing together scientists and regulators from around the globe for experiential education in these new technologies.

OUR PARTNERS